Results for “”

Entry Author Date Location
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie 01/27/20 National
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Epizyme’s Soft Tissue Cancer Drug Granted Speedy FDA Approval 01/23/20 Boston
After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune 01/23/20 National
Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment 01/22/20 National
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal 01/16/20 Boston
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data 01/14/20 National
Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive 01/14/20 San Diego
Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug 01/13/20 National
Neurocrine, in Second Epilepsy Deal, Pairs With Swiss Biotech Idorsia 01/11/20 San Diego
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Saniona Taps Former Sobi North America President Rami Levin as New CEO 01/09/20 Boston
UK Startups Double in Number Backed By Larger Scale Investments: Report 01/09/20 National
Novo Holdings Repositions Antibiotics Funding Amid “Deteriorated” Market 01/07/20 National
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto 01/07/20 San Diego
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic 01/07/20 Boston
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Rexgenero CEO Talks Importance of “Dialogue” in Cell Therapy Conversations 01/02/20 National
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines 12/24/19 National
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal 12/23/19 Boston
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More 12/20/19 National
FTC Challenges PacBio Acquisition, Says Illumina is a “Monopolist” 12/18/19 San Diego
ALS Fund Talks Investments and Strategy as it Kicks Off $100M Campaign 12/17/19 National
Cell Reprogramming Startup Bit Bio Inks Pact With Charles River 12/16/19 Boston
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning 12/12/19 National
Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink 12/11/19 National
Page 1 of 1